Disulfiram
Disulfiram is a pharmaceutical drug with 41 clinical trials. Currently 3 active trials ongoing. Historical success rate of 79.4%.
Success Metrics
Based on 27 completed trials
Phase Distribution
Phase Distribution
18
Early Stage
15
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
27 of 36 finished
25.0%
9 ended early
3
trials recruiting
41
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Clinical Trials (41)
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform
Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease
Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
Disulfiram and Cisplatin in Refractory TGCTs.
DISulfiram for COvid-19 (DISCO) Trial
A Study of the Relationship Between Disulfiram and Cocaine Self-administration.
Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma
Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use Disorder
Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer
Disulfiram in Recurrent Glioblastoma
Neural Mechanisms of Disulfiram Effects
Disulfiram for Cocaine Abuse in Buprenorphine Treatment
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 41